Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CRISPR-Cas9 for treating hereditary diseases.

Progress in molecular biology and translational science - 1 Jan 2021

Mani Indra

Abstract excerpt

This chapter analyzes to use of the genome editing tool to the treatment of various genetic diseases. The genome editing method could be used to change the DNA in cells or organisms to understand their physiological response. Therefore, a key objective is to present general information about the use of the genome editing tool in a pertinent way. An emerging genome editing technology like a clustered regularly...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR-Cas Systems
Share to Gene Editing
Share to Genetic Therapy

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Source

Identifiers

PMID: 34127193
DOI: 10.1016/bs.pmbts.2021.01.017

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CRISPR-Cas9 for treating hereditary diseases.PMID 34127193Read ↗

Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicineSemantic proximity Read ↗

Current approaches in CRISPR-Cas9 mediated gene editing for biomedical and therapeutic applications.Semantic proximity Read ↗

An introduction to CRISPR-Cas systems for reprogramming the genome of mammalian cells.Semantic proximity Read ↗

Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy.Semantic proximity Read ↗

Genome editing: A perspective on the application of CRISPR/Cas9 to study human diseases (Review)Semantic proximity Read ↗

CRISPR-Cas Systems in Human Disease: A Targeted Review of Innovations Across Five DisordersSemantic proximity Read ↗

Progress and Perspective of CRISPR‐Cas9 Technology in Translational MedicineSemantic proximity Read ↗

CRISPR: A new paradigm of theranostics.Semantic proximity Read ↗

CRISPR/Cas9-mediated genome editing: From basic research to translational medicine.Semantic proximity Read ↗

CRISPR Editing in Biological and Biomedical Investigation.Semantic proximity Read ↗

The Control and Trust of CRISPR / Cas9 Genome Altering for Clinical Application with Gene Treatment and Treatment of Hereditary DiseasesSemantic proximity Read ↗

Crispr-cas System: Classification, Benefits, Applications And FunctionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.